1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Tandem Mass Spectrometry
1.2.3 Immunoassay
1.3 Market by Application
1.3.1 Global Endocrine Testing Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospitals
1.3.3 Commercial Laboratories
1.3.4 Ambulatory Care Centres
1.3.5 Other Setting
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Testing Market Perspective (2018-2032)
2.2 Endocrine Testing Growth Trends by Region
2.2.1 Endocrine Testing Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Endocrine Testing Historic Market Size by Region (2018-2023)
2.2.3 Endocrine Testing Forecasted Market Size by Region (2023-2032)
2.3 Endocrine Testing Market Dynamics
2.3.1 Endocrine Testing Industry Trends
2.3.2 Endocrine Testing Market Drivers
2.3.3 Endocrine Testing Market Challenges
2.3.4 Endocrine Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Testing Players by Revenue
3.1.1 Global Top Endocrine Testing Players by Revenue (2018-2023)
3.1.2 Global Endocrine Testing Revenue Market Share by Players (2018-2023)
3.2 Global Endocrine Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endocrine Testing Revenue
3.4 Global Endocrine Testing Market Concentration Ratio
3.4.1 Global Endocrine Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Testing Revenue in 2022
3.5 Endocrine Testing Key Players Head office and Area Served
3.6 Key Players Endocrine Testing Product Solution and Service
3.7 Date of Enter into Endocrine Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Testing Breakdown Data by Type
4.1 Global Endocrine Testing Historic Market Size by Type (2018-2023)
4.2 Global Endocrine Testing Forecasted Market Size by Type (2023-2032)
5 Endocrine Testing Breakdown Data by Application
5.1 Global Endocrine Testing Historic Market Size by Application (2018-2023)
5.2 Global Endocrine Testing Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Endocrine Testing Market Size (2018-2032)
6.2 North America Endocrine Testing Market Size by Country (2018-2023)
6.3 North America Endocrine Testing Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Endocrine Testing Market Size (2018-2032)
7.2 Europe Endocrine Testing Market Size by Country (2018-2023)
7.3 Europe Endocrine Testing Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Testing Market Size (2018-2032)
8.2 Asia-Pacific Endocrine Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Endocrine Testing Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Endocrine Testing Market Size (2018-2032)
9.2 Latin America Endocrine Testing Market Size by Country (2018-2023)
9.3 Latin America Endocrine Testing Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Testing Market Size (2018-2032)
10.2 Middle East & Africa Endocrine Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Endocrine Testing Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Endocrine Testing Introduction
11.1.4 Abbott Laboratories Revenue in Endocrine Testing Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 AdnaGen
11.2.1 AdnaGen Company Detail
11.2.2 AdnaGen Business Overview
11.2.3 AdnaGen Endocrine Testing Introduction
11.2.4 AdnaGen Revenue in Endocrine Testing Business (2018-2023)
11.2.5 AdnaGen Recent Development
11.3 Beckman Coulter/Danaher
11.3.1 Beckman Coulter/Danaher Company Detail
11.3.2 Beckman Coulter/Danaher Business Overview
11.3.3 Beckman Coulter/Danaher Endocrine Testing Introduction
11.3.4 Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2018-2023)
11.3.5 Beckman Coulter/Danaher Recent Development
11.4 Biomedical Diagnostics
11.4.1 Biomedical Diagnostics Company Detail
11.4.2 Biomedical Diagnostics Business Overview
11.4.3 Biomedical Diagnostics Endocrine Testing Introduction
11.4.4 Biomedical Diagnostics Revenue in Endocrine Testing Business (2018-2023)
11.4.5 Biomedical Diagnostics Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Detail
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Endocrine Testing Introduction
11.5.4 BioMerieux Revenue in Endocrine Testing Business (2018-2023)
11.5.5 BioMerieux Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Endocrine Testing Introduction
11.6.4 Bio-Rad Revenue in Endocrine Testing Business (2018-2023)
11.6.5 Bio-Rad Recent Development
11.7 Dako
11.7.1 Dako Company Detail
11.7.2 Dako Business Overview
11.7.3 Dako Endocrine Testing Introduction
11.7.4 Dako Revenue in Endocrine Testing Business (2018-2023)
11.7.5 Dako Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Detail
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Endocrine Testing Introduction
11.8.4 DiaSorin Revenue in Endocrine Testing Business (2018-2023)
11.8.5 DiaSorin Recent Development
11.9 Eiken
11.9.1 Eiken Company Detail
11.9.2 Eiken Business Overview
11.9.3 Eiken Endocrine Testing Introduction
11.9.4 Eiken Revenue in Endocrine Testing Business (2018-2023)
11.9.5 Eiken Recent Development
11.10 Fujirebio
11.10.1 Fujirebio Company Detail
11.10.2 Fujirebio Business Overview
11.10.3 Fujirebio Endocrine Testing Introduction
11.10.4 Fujirebio Revenue in Endocrine Testing Business (2018-2023)
11.10.5 Fujirebio Recent Development
11.11 Instrumentation Laboratory
11.11.1 Instrumentation Laboratory Company Detail
11.11.2 Instrumentation Laboratory Business Overview
11.11.3 Instrumentation Laboratory Endocrine Testing Introduction
11.11.4 Instrumentation Laboratory Revenue in Endocrine Testing Business (2018-2023)
11.11.5 Instrumentation Laboratory Recent Development
11.12 Kyowa Medex
11.12.1 Kyowa Medex Company Detail
11.12.2 Kyowa Medex Business Overview
11.12.3 Kyowa Medex Endocrine Testing Introduction
11.12.4 Kyowa Medex Revenue in Endocrine Testing Business (2018-2023)
11.12.5 Kyowa Medex Recent Development
11.13 Matritech
11.13.1 Matritech Company Detail
11.13.2 Matritech Business Overview
11.13.3 Matritech Endocrine Testing Introduction
11.13.4 Matritech Revenue in Endocrine Testing Business (2018-2023)
11.13.5 Matritech Recent Development
11.14 Ortho-Clinical Diagnostics
11.14.1 Ortho-Clinical Diagnostics Company Detail
11.14.2 Ortho-Clinical Diagnostics Business Overview
11.14.3 Ortho-Clinical Diagnostics Endocrine Testing Introduction
11.14.4 Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2018-2023)
11.14.5 Ortho-Clinical Diagnostics Recent Development
11.15 Roche
11.15.1 Roche Company Detail
11.15.2 Roche Business Overview
11.15.3 Roche Endocrine Testing Introduction
11.15.4 Roche Revenue in Endocrine Testing Business (2018-2023)
11.15.5 Roche Recent Development
11.16 Siemens
11.16.1 Siemens Company Detail
11.16.2 Siemens Business Overview
11.16.3 Siemens Endocrine Testing Introduction
11.16.4 Siemens Revenue in Endocrine Testing Business (2018-2023)
11.16.5 Siemens Recent Development
11.17 Sysmex
11.17.1 Sysmex Company Detail
11.17.2 Sysmex Business Overview
11.17.3 Sysmex Endocrine Testing Introduction
11.17.4 Sysmex Revenue in Endocrine Testing Business (2018-2023)
11.17.5 Sysmex Recent Development
11.18 Thermo Fisher
11.18.1 Thermo Fisher Company Detail
11.18.2 Thermo Fisher Business Overview
11.18.3 Thermo Fisher Endocrine Testing Introduction
11.18.4 Thermo Fisher Revenue in Endocrine Testing Business (2018-2023)
11.18.5 Thermo Fisher Recent Development
11.19 Tosoh
11.19.1 Tosoh Company Detail
11.19.2 Tosoh Business Overview
11.19.3 Tosoh Endocrine Testing Introduction
11.19.4 Tosoh Revenue in Endocrine Testing Business (2018-2023)
11.19.5 Tosoh Recent Development
11.20 Wako
11.20.1 Wako Company Detail
11.20.2 Wako Business Overview
11.20.3 Wako Endocrine Testing Introduction
11.20.4 Wako Revenue in Endocrine Testing Business (2018-2023)
11.20.5 Wako Recent Development
11.21 Wallac/PE
11.21.1 Wallac/PE Company Detail
11.21.2 Wallac/PE Business Overview
11.21.3 Wallac/PE Endocrine Testing Introduction
11.21.4 Wallac/PE Revenue in Endocrine Testing Business (2018-2023)
11.21.5 Wallac/PE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
